Step-up Therapy with Skin Barrier Repair Emulsion in Personal Protective Equipment (PPE) Associated Adverse Skin Reactions during the COVID-19 Pandemic

Main Article Content

Katlyn Anderson
Arkansas Dermatology and Skin Cancer Center, Little Rock, AR

Keywords

Pharmacology, Skin Barrier Repair, Step-Up Therapy, COVID-19, Personal Protective Equipment

Abstract

Abstract not available.

References

1.Foo CC, Goon A, Leow YH, et al. Adverse skin reactions to personal protective equipment against severe acute respiratory syndrome – a descriptive study in Singapore. Contact Dermatitis 2006: 55: 291–294

2. Hu K, Fan J, Li X, Gou X, Li X, Zhou X. The adverse skin reactions of health care workers using personal protective equipment for COVID-19. Medicine 2020;99:24(e20603)

3.Centers for Disease Control and Prevention. Hand Hygiene Recommendations Guidance for Healthcare Providers about Hand Hygiene and COVID-19. https://www.cdc.gov/coronavirus/2019-ncov/hcp/hand-hygiene.html. Accessed 21 Sept 2020

4. Elias PM, Wakefield JS, Man M. Moisturizers versus Current and Next-Generation Barrier Repair Therapy for the Management of Atopic Dermatitis. Skin Pharmacol Physiol 2019;32:1–7

Article Sidebar

Poster PDF
Published
Oct 27, 2020
DOI https://doi.org/10.25251/skin.4.supp.115

Article Details

How to Cite
Anderson, K. (2020). Step-up Therapy with Skin Barrier Repair Emulsion in Personal Protective Equipment (PPE) Associated Adverse Skin Reactions during the COVID-19 Pandemic. SKIN The Journal of Cutaneous Medicine, 4(6), s115. https://doi.org/10.25251/skin.4.supp.115
Issue
Vol. 4 No. 6 (2020): November Issue & Poster Presentations (FC20 Dermatology Conference®)
Section
Miscellaneous
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.